20th Jun 2018 16:22
Consort Medical plc (the 'Company')
Director/PDMR shareholding
20 June 2018
Consort Medical plc announces that a director and a person discharging managerial responsibilities ('PDMR') as detailed below, have exercised awards over ordinary shares in the Company ('Ordinary Shares') in accordance with the terms of the Consort Medical plc Deferred Bonus Plan (the 'DBP') and the Consort Medical Performance Share Plan (the 'PSP') (together the 'Awards').
The Awards were exercised for nil consideration on 19 June 2018 pursuant to respective awards made on 19 June 2015.
The exercise of the Awards was satisfied out of the Ordinary Shares held in the Consort Medical plc Employee Share Ownership Trust.
Also on 19 June 2018, the same director and PDMR below disposed of Ordinary Shares at £12.20 per share with the net proceeds of Mr Glenn's disposal used to cover tax liabilities associated to the above exercise of the Awards only. The relevant director's and PDMR's resultant interests in the Ordinary Shares of the Company are shown below.
Individual | Director /PDMR | Ordinary Shares exercised under the DBP | Ordinary Shares exercised under the PSP | Total Ordinary Shares exercised
| Total Ordinary Shares sold
| Total Ordinary shares retained | Total resultant Ordinary Shares held | % of Ordinary Share capital held |
Jonathan Glenn | Director | 23,855 | nil | 23,855 | 11,212 | 12,643 | 165,341 | 0.34 |
Keyvan Djamarani | PDMR | 5,688 | 16,716 | 22,404 | 22,404 | nil | 21,449 | 0.04 |
The Company was informed of the above transactions by the Consort Medical Employee Share Ownership Trust on 20 June 2018.
Mr Glenn's resultant increased shareholding of 165,341 Ordinary Shares equates to a 4.1x multiple of his salary (calculated using the exercise share price of £12.20 per share).
Enquiries: Michelle Palmer Assistant Company Secretary 01442 867920
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
|
Jonathan Glenn | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| CEO | |||
b)
| Initial notification /Amendment
| Initial | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Consort Medical plc | |||
b)
| LEI
| 2138001TBP74FD66QT38 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary 10p shares | |||
Identification code | ISIN: GB0000946276 | ||||
b)
| Nature of the transaction
| Exercise of Deferred Bonus Plan shares | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
0 | 23,855
| ||||
d)
| Aggregated information | ||||
n/a | |||||
- Aggregated volume | |||||
- Price | |||||
e)
| Date of the transaction
| 19 June 2018 | |||
f)
| Place of the transaction
| Off market transaction | |||
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
|
Jonathan Glenn | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| CEO | |||
b)
| Initial notification /Amendment
| Initial | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Consort Medical plc | |||
b)
| LEI
| 2138001TBP74FD66QT38 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary 10p shares | |||
Identification code | ISIN: GB0000946276 | ||||
b)
| Nature of the transaction
| Sale of Deferred Bonus Plan shares to cover the Tax and NI liabilities associated with the exercise of the Award | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
12.20 | 11,212 | ||||
d)
| Aggregated information | ||||
n/a | |||||
- Aggregated volume | |||||
- Price | |||||
e)
| Date of the transaction | 19 June 2018 | |||
f)
| Place of the transaction
| Off market transaction | |||
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
|
Keyvan Djamarani | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Managing Director Bespak Division | |||
b)
| Initial notification /Amendment
| Initial | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Consort Medical plc | |||
b)
| LEI
| 2138001TBP74FD66QT38 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary 10p shares | |||
Identification code | ISIN: GB0000946276 | ||||
b)
| Nature of the transaction
| Exercise of Deferred Bonus Plan and Performance Share Plan shares | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
0 | 22,404 | ||||
d)
| Aggregated information | ||||
n/a | |||||
- Aggregated volume | |||||
- Price | |||||
e)
| Date of the transaction
| 19 June 2018 | |||
f)
| Place of the transaction
| Off market transaction | |||
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
|
Keyvan Djamarani | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Managing Director Bespak Division | |||
b)
| Initial notification /Amendment
| Initial | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Consort Medical plc | |||
b)
| LEI
| 2138001TBP74FD66QT38 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary 10p shares | |||
Identification code | ISIN: GB0000946276 | ||||
b)
| Nature of the transaction
| Sale of Deferred Bonus Plan and Performance Share Plan shares with part of the sale being used to cover the Tax and NI liabilities associated with the exercise of the Awards | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
12.20 | 22,404 | ||||
d)
| Aggregated information | ||||
n/a | |||||
- Aggregated volume | |||||
- Price | |||||
e)
| Date of the transaction | 19 June 2018 | |||
f)
| Place of the transaction
| Off market transaction | |||
Related Shares:
CSRT.L